By Kiran Mazumdar Shaw, CMD, Biocon 2017 has been an exciting year for science in…
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S.…
Financial Chronicle: Big Interview: Biocon CMD Kiran Mazumdar-Shaw spoke to FC on a range of…
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, tells P.B. Jayakumar about the key lessons she has learnt in business life.
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s…
Is India Inc.’s new found enthusiasm to have woman board members a reflection of changing…
A couple of years ago, India celebrated the success of its first Mars mission and…
The new fiscal year promises exciting opportunities for the Indian economy, which is scheduled to…
19th of April is a historic day for India’s space mission. On this day, 42 years…
2016 was a landmark year for India as demonetisation nudged the country towards an inclusive,…
